Seamless Adoption of Mid-Study Protocol Change
An emerging biotech firm conducting a complex Phase III trial was facing a protocol change that would render the Interactive Response Technology (IRT) system for Part II of the study unusable. This case study reveals the innovative solution and IRT platform that allowed the firm to meet their goals without interruption or patients lost.
- Cost-effective solutions for procuring and dispensing medication
- Risks associated with amending the protocol and then employing sound solutions
- The benefits of a total view over distribution logistics